Cannabis Law Report

SEPTEMBER 14, 2021

A lack of consumer trust, transparency and scientific rigor has hampered the CBD and cannabinoid industry from reaching its growth potential for far too long”. Headquartered in Roxboro, N.C.,

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

JUNE 8, 2021

Cannabidiol or CBD is a natural cannabinoid that actively affects the human body. It is prescribed by psychotherapists as an alternative to antidepressants and sleeping pills. The previously forbidden plant is gaining incredible popularity. And all thanks to the latest medical research. Moreover, the effect is curative.

Research and Development 98

Research and Development CBD Environment Supply Chain 98

CannaTech

AUGUST 9, 2020

Companies are going beyond adding new flavors and are investing in research & development to introduce new products that contain botanical ingredients and minor cannabinoids CBG and CBN alongside CBD to offer additional benefits. CBG (cannabigerol) is believed to have antimicrobial, analgesic or anti-inflammatory properties.

CBD 52

CBD Wellness and Beauty Extraction Retail 52

SpeedWeed

JULY 8, 2021

Speaking with Cannabis Business Times and Hemp Grower , Clever Leaves CEO Kyle Detwiler said he and others at the company see Mexico as a “great demand center for medical cannabis, for other cannabinoid products.”. A lot of these countries are just beginning their cannabinoid journey.”. Detwiler said. “I Detwiler said. “A

Pharmaceutical 52

Pharmaceutical Cannabinoids Supply Chain Cultivation 52

Cannabis Law Report

AUGUST 6, 2021

The Ace Valley Dream gummies contain the CBN minor cannabinoid which lends itself to a key consumer need state, sleep. Asset impairments related to periodic changes to the Company’s supply chain processes are not excluded from Adjusted EBITDA given their occurrence through the normal course of core operational activities.

Vaping 105

Vaping Research and Development Data Business 105

SpeedWeed

JULY 8, 2021

Speaking with Cannabis Business Times and Hemp Grower , Clever Leaves CEO Kyle Detwiler said he and others at the company see Mexico as a “great demand center for medical cannabis, for other cannabinoid products.”. A lot of these countries are just beginning their cannabinoid journey.”. Detwiler said. “I Detwiler said. “A

Pharmaceutical 40

Pharmaceutical Cannabinoids Supply Chain Cultivation 40

SpeedWeed

JULY 7, 2021

Speaking with Cannabis Business Times and Hemp Grower , Clever Leaves CEO Kyle Detwiler said he and others at the company see Mexico as a “great demand center for medical cannabis, for other cannabinoid products.”. A lot of these countries are just beginning their cannabinoid journey.”. Detwiler said. “I Detwiler said. “A

Pharmaceutical 40

Pharmaceutical Cannabinoids Supply Chain Cultivation 40

SpeedWeed

JULY 7, 2021

Speaking with Cannabis Business Times and Hemp Grower , Clever Leaves CEO Kyle Detwiler said he and others at the company see Mexico as a “great demand center for medical cannabis, for other cannabinoid products.”. A lot of these countries are just beginning their cannabinoid journey.”. Detwiler said. “I Detwiler said. “A

Research and Development 40

Research and Development Pharmaceutical Cannabinoids Supply Chain 40

SpeedWeed

JULY 6, 2021

Speaking with Cannabis Business Times and Hemp Grower , Clever Leaves CEO Kyle Detwiler said he and others at the company see Mexico as a “great demand center for medical cannabis, for other cannabinoid products.”. A lot of these countries are just beginning their cannabinoid journey.”. Detwiler said. “I Detwiler said. “A

Pharmaceutical 40

Pharmaceutical Cannabinoids Supply Chain Cultivation 40

Cannabis Law Report

JUNE 1, 2021

Improved supply chain execution and quality enhancements are leading to commercial success. ” “We made tremendous progress improving our supply chain and right-sizing our manufacturing footprint, bringing supply and demand into balance,” added Mike Lee , CFO. opportunities in Fiscal 2022.”

Data 95

Data Vaping Supply Chain Business 95

The Cannigma

FEBRUARY 3, 2022

I think those women probably don’t experience the psychoactivity that other women might too if they don’t have as much local effect of their cannabinoids but I do think they definitely work. We don’t know how your particular brain is going to respond to this particular mix of cannabinoids and terpenes. CP: Almost locally.

Wellness and Beauty 135

Wellness and Beauty Patients Medicine Cannabis 135

The Cannigma

JANUARY 19, 2022

This is not just foo-foo, there’s plenty of early evidence to suggest that there might be something here about cannabinoids as neuroprotectants and also as neurogenic helpers and sort of helping us heal our brains. I mean, asking questions was like, how can I function, how can I sleep, how can I not be in pain. EG: Definitely.

Patients 98

Patients Compliance Compliance Cannabis 98